...
首页> 外文期刊>Saudi Pharmaceutical Journal >The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia
【24h】

The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia

机译:药物经济学在沙特阿拉伯利雅得各医院处方决策中的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To assess the trend of using pharmacoeconomic information by Pharmacy and Therapeutics (P&T) committees when making formulary decisions. Design: A cross-sectional study conducted in 2007, using structured survey questionnaires which were distributed to members of the P&T committees in 11 different hospitals in Riyadh, Saudi Arabia. Results: A total of 100 survey questionnaires were sent to head of pharmacy departments of 11 different hospitals in Riyadh, Saudi Arabia. Out of these, 48 questionnaires were completed and returned. Of the total respondents participated in the study, 64.58% were medical doctors and 16.66% were pharmacists and 75% of the respondents said they have applied pharmacoeconomic evaluations in their decision making process. More than 80% of the respondents perceived that they had a fair knowledge of pharmacoeconomics. Approximately 80% of respondents expressed some degree of agreement that pharmacoeconomics should be applied as a decision making tool. The majority of decision-makers (95%) expressed the interest in attending workshops on pharmacoeconomics. Conclusion: The study showed that pharmacoeconomics can play an important role in the P&T committee formulary decisions. However, more education to health care professionals and to hospital administrators should be conducted to facilitate the use of such a tool. Also, hospitals should recruit health care professionals with pharmacoeconomic expertise to manage limited health resources in the best way available.
机译:目的:评估制定处方时药房和治疗学(P&T)委员会使用药物经济学信息的趋势。设计:2007年进行的横断面研究,使用结构化调查问卷分发给沙特阿拉伯利雅得11家不同医院的P&T委员会成员。结果:共向沙特阿拉伯利雅得11家不同医院的药房部门负责人发送了100份调查问卷。其中,完成并退回了48份问卷。在参与研究的所有受访者中,有64.58%是医生,有16.66%是药剂师,而75%的受访者表示他们在决策过程中采用了药物经济学评估。超过80%的受访者认为他们对药物经济学有一定的了解。大约80%的受访者表示一定程度的同意应将药物经济学用作决策工具。大多数决策者(95%)表示有兴趣参加药物经济学研讨会。结论:研究表明,药物经济学在P&T委员会制定处方中可以发挥重要作用。但是,应该对医疗保健专业人员和医院管理人员进行更多的培训,以促进使用这种工具。此外,医院应招募具有药物经济学专业知识的卫生保健专业人员,以可用的最佳方式管理有限的卫生资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号